2 Beaten-Down Stocks With Massive Upside Potential

CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics (NASDAQ: CRSP) and Viking Therapeutics (NASDAQ: VKTX), two mid-cap biotech companies that have lagged broader equities over the trailing-12-month period.